Tuftsin-derived peptide studied for neuromodulation.
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin used in central-nervous-system research.
Influences GABAergic and serotonergic systems and modulates expression of BDNF in research models.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Profiled GABA-system gene expression in hippocampus after Selank exposure.
Up-regulated GABA-A subunit transcription consistent with anxiolytic phenotype.
Behavior and BDNF mRNA quantified under chronic Selank dosing.
Normalized exploratory behavior and increased hippocampal BDNF transcription.
Cognitive performance under Selank after chemical cholinergic disruption.
Partial recovery of learning/memory tasks vs. lesioned controls.
Lyophilized -20°C.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Selank is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
